Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Apitoxin is a new biological drug for pain & inflammation and arthritis, approved by the Korean FDA on May 3, 2003 after 14 years of preclinical, animal, and phase I, II & III clinical studies More
Capsaicin, the active ingredient found in red-hot peppers, is used mainly for the relief of chronic pain of rheumatoid arthritis and osteoarthritis More
Range of Glucosamine based pharmaceutical products (capsule,tablets,sachets,) authorized in some countries of Europe or ready to register. More
Our client is looking for partners to further develop and commercialize stem cells, sourced from adipose tissue for the treatment of regenerative medicine and ageing. More
Scientists at the forefront of regenerative medicine based at the Biomatcell Vinn Excellence Center of Biomaterials have identified this small molecule platform with these unique osteogenic differentiating properties and are now looking to develop them. More
Our products (KH-207 and KD-30) related to treatment of osteoarthritis focus on increase of chondrogenesis through cartilage protection as well as beneficial effects (decrease of pain and stiffness and improvement of function). We propose an alterna More
CG100649 is a lead candidate being developed as osteoarthritis therapeutic and is currently in Phase II clinical stage More
Composition for preventing bone loss comprising salvia miltiorrhiza extracts and chitosan More
Scientists at the forefront of regenerative medicine based at the Biomatcell Vinn Excellence Center of Biomaterials have identified this small molecule platform with these unique osteogenic differentiating properties and are now looking to develop them. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 577 pages - $1,495
Nov 2010 - 40 pages - $500
Jun 2006 - 378 pages - $2,495
Mar 2011 - 82 pages - $500
Feb 2011 - 43 pages - $1,000
Feb 2011 - 60 pages - $500
Sep 2011 - 105 pages - $500
Oct 2010 - 169 pages - $3,500
Dec 2010 - 84 pages - $500
Dec 2010 - 42 pages - $2,000
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us